NUVA 44.25 Nuvasive Inc $NUVA Hit a 52 week high of 44.31

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
NUVA 44.25 Nuvasive Inc $NUVA Hit a 52 week high of 44.31 Closing the day 09:45 at 44.25 +0.35 +0.80% With a day low of 43.91 and a total volume of 13,413.

NUVA Recent Posts: http://investorshangout.com/NuVasive-Inc-NUVA-54931/

NUVA Nuvasive Inc Recent Headline News

Shares of NUVA Up 23.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 17, 5:50PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 23.09% as of today's recent price of $43.90.
NUVA: 44.06 (+0.16)

NuVasive Earnings Review: 18 Days after Announcement Shares Up 11.5% (NUVA)
Comtex SmarTrend(R) - Mon Nov 17, 2:42PM CST
Two weeks ago on October 30th, 2014 NuVasive (NASDAQ:NUVA) reported earnings and analysts, on average, expected earnings of $0.25 on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $43.78, representing a gain of 11.5% in the past 18 days.
NUVA: 44.06 (+0.16)

NuVasive (NUVA) Flagged As Strong On High Volume
at The Street - Mon Nov 17, 9:00AM CST
Trade-Ideas LLC identified NuVasive (NUVA) as a strong on high relative volume candidate
NUVA: 44.06 (+0.16)

Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Mon Nov 17, 7:55AM CST
NuVasive (NASDAQ:NUVA) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $43.78 on volume of 481,000 shares, above average daily volume of 341,000. NuVasive has overhead space with shares priced $43.78, or 8.7% below the average consensus analyst price target of $47.93. The stock should discover initial support at its 50-day moving average (MA) of $37.43 and subsequent support at its 200-day MA of $35.89.
NUVA: 44.06 (+0.16)

NuVasive (NUVA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:13AM CST
NuVasive (NUVA) Shares March Higher, Can It Continue?
NUVA: 44.06 (+0.16)

NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting
Marketwired - Mon Nov 10, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive or the "Company" , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society ("NASS" Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company's attendance underscores NuVasive's ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company's products and procedures that have revolutionized the spine industry.
NUVA: 44.06 (+0.16)

NuVasive Has Returned 18.5% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 18.46% as of today's recent price of $42.25.
NUVA: 44.06 (+0.16)

NuVasive Earnings Hindsight: Up 6.3% in Last 11 Days (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 11:41AM CST
11 days ago, on October 30th, 2014, NuVasive (NASDAQ:NUVA) reported its earnings. Analysts, on average, expected earnings of $0.25 per share on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $41.75, representing a gain of 6.3% in the past 11 days.
NUVA: 44.06 (+0.16)

Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come  out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 111.55 (+0.87), BSX: 13.47 (+0.09), MDT: 71.94 (+2.75), NUVA: 44.06 (+0.16)

Update: NuVasive Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 07, 3:09PM CST

NUVA: 44.06 (+0.16)

Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include SANM, NUVA and EMC
EMC: 30.61 (+0.23), NUVA: 44.06 (+0.16), SANM: 24.91 (+0.26)

Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 143.63 (+1.58), LMT: 185.58 (+0.07), MDT: 71.93 (+2.74), QDEL: 28.16 (+0.25), XOM: 95.06 (-0.05), CLF: 10.05 (-0.80), BA: 130.33 (+1.91), NUVA: 44.06 (+0.16), ANR: 2.47 (-0.14), BSX: 13.47 (+0.09), VLO: 49.76 (+0.04), BTU: 11.30 (-0.22), ABAX: 54.77 (+0.11), IMO: 47.81 (-0.17), ACI: 2.57 (-0.08)

NuVasive to Host Investor Morning on November 13, 2014
Marketwired - Mon Nov 03, 3:09PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company" , a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts on Thursday, November 13, 2014 from 8:00 a.m. to 10:00 a.m. PT at the W Hotel in San Francisco, California.
NUVA: 44.06 (+0.16)

NuVasive Shares Up 16.2% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:57AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 4 months, NuVasive has returned 16.22% as of today's recent price of $41.45.
NUVA: 44.06 (+0.16)

NuVasive spikes 3.8% after guidance update
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:15PM CDT

NUVA: 44.06 (+0.16)

NuVasive's (NUVA) CEO Alex Lukianov on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 12:15AM CDT

NUVA: 44.06 (+0.16)

NuVasive (NUVA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:25PM CDT

NUVA: 44.06 (+0.16)

NuVasive misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:43PM CDT

NUVA: 44.06 (+0.16)

NuVasive Inc. (NUVA) Stock Research Links

NUVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Katahdin's Portland Branch Bet Moves Downtown in 2027

Updated Category News Views 61

Exchange Street is getting a real-world vote of confidence, and that is more interesting than another app update ever will be. Katahdin Trust intends to open a full-service branch at 120 Exchange Street in downtown Portland, with renovations slated to begin early in 2027 and an opening expected later that year. For a Maine community bank with nearly $1.2 billion in...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 10

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 20

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
CVRx Lawsuit Deadline Follows a Brutal 59.76% Plunge

Updated Category News Views 24

A 59.76% one-day wipeout has a way of stripping the varnish off every upbeat corporate story. For CVRx investors, the hard fact is that the shares fell $3.55 to close at $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That kind of disclosure does not merely dent confidence; it forces...

Continue Reading
Haemonetics Opens Europe for VASCADE MVP XL Device

Updated Category News Views 31

A larger collagen plug is hardly cocktail-party material, yet it can matter a great deal when it sits inside a procedure workflow hospitals are trying to speed up. Haemonetics has received CE Mark certification under the EU Medical Device Regulation for VASCADE MVP XL, its larger-bore venous vascular closure system, and first commercial European procedures were completed...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 85

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 31

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 68

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 68

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 0

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier Global Under Fire: An Investor's Investigation

Updated Category News Views 63

Sometimes the heat in the boardroom can match the heat of a summer's day. Enter Carrier Global Corporation (NYSE: CARR), where a group of folks who should've had their numbers kept tidy started playing with fire. Now there's an invite to a showdown from Schall, Brown & Schwartz LLP. They've thrown down the gauntlet to dig into whether Carrier’s statements could put them...

Continue Reading
Wise Group Faces Class Action Over Misleading Statements

Updated Category News Views 15

Wise Group plc: Legal Storm Brewing on the Horizon Looks like Wise Group's NASDAQ journey might be hitting some turbulence. Shareholders who picked up shares of the NASDAQ ticker WSE between May 11 and July 23, 2026, are getting a nudge to join a class action lawsuit that's gaining steam. Nothing sends a chill down a stockholder’s spine quite like the term "materially...

Continue Reading
FTI Consulting Enhances AI Capabilities with New Leadership

Updated Category News Views 151

FTI Consulting Announces New Senior Director for AI Innovation Global business advisory firm FTI Consulting, Inc. (NYSE: FCN), has recently appointed Brian Knudson as Senior Managing Director in the Data & Technology Transformation practice within the Corporate Finance & Restructuring segment. This strategic hire showcases FTI's commitment to enhancing its capabilities in...

Continue Reading
Viasat Launches Government Services via ViaSat-3 F1 Satellite

Updated Category News Views 156

Viasat Launches Government Services via ViaSat-3 F1 Satellite Viasat is now providing crucial satellite services to the U.S. Marine Corps using the ViaSat-3 network. This launch marks a significant stride towards enhancing connectivity for government operations. Connecting Military Operations The Marine Wing Communications Squadron 38 (MWCS-38) and the 3rd Marine Littoral...

Continue Reading
Automatic Trash Cans: A Game-Changer for Households

Updated Category News Views 87

Tired of Wrestling with Trash Cans? You'd think in this high-tech era, someone would've cracked the code on trash day drudgery. Well folks, the TRASH HAULER might just be the answer. Created by an inventive mind from Manhattan, Kansas, this gizmo is out to revolutionize the way we handle our garbage—by doing the heavy lifting for us on pickup day. The Idea Behind TRASH...

Continue Reading